578 related articles for article (PubMed ID: 32564470)
41. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
44. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
[TBL] [Abstract][Full Text] [Related]
45. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
46. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
47. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
48. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
49. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
Ping G; Tian Y; Zhou Z
Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
[TBL] [Abstract][Full Text] [Related]
50. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
[TBL] [Abstract][Full Text] [Related]
51. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
52. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
53. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
54. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
Zhao J; Xu J; Shang AQ; Zhang R
Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
[TBL] [Abstract][Full Text] [Related]
55. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
[TBL] [Abstract][Full Text] [Related]
56. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
[TBL] [Abstract][Full Text] [Related]
57. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
Front Genet; 2021; 12():635863. PubMed ID: 33719345
[No Abstract] [Full Text] [Related]
58. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
59. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
[No Abstract] [Full Text] [Related]
60. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]